Clin Pediatr Hematol Oncol.  2015 Oct;22(2):176-180. 10.15264/cpho.2015.22.2.176.

A Hypervascular Inflammatory Myofibroblastic Tumor in the Mediastinum Resected Completely Following Embolization of the Feeding Vessels

Affiliations
  • 1Department of Pediatrics, Hanyang University College of Medicine, Seoul, Korea. cord@hanyang.ac.kr
  • 2Department of Radiology, Hanyang University College of Medicine, Seoul, Korea.
  • 3Department of Thoracic and Cardiovascular Surgery, Hanyang University College of Medicine, Seoul, Korea.
  • 4Department of Pathology, Hanyang University College of Medicine, Seoul, Korea.

Abstract

Inflammatory myofibroblastic tumors (IMTs) are rare tumors of intermediate malignant potential that can occur anywhere in the body. We describe an interesting case of a hypervascular IMT in the mediastinum that could be resected completely following embolization of the feeding vessels. A 17-month-old girl with complaints of cough and fever for 3 months was referred to our hospital. Computed tomography (CT) scan showed a large mass in the right hemithorax that shifted the mediastinum to the left. Primary excision was considered but not performed because there was very active capsule wall bleeding due to the hypervascular tumor. After embolization of the feeding vessels, successful complete resection was carried out. Approximately 6 weeks after the operation, follow-up CT scan showed no evidence of recurrent disease. Preoperative embolization is a good option for performing complete resection of hypervascular IMTs that could reduce the recurrence rate.

Keyword

Inflammatory pseudotumor; Mediastinal neoplasms; Therapeutic embolization

MeSH Terms

Cough
Embolization, Therapeutic
Female
Fever
Follow-Up Studies
Granuloma, Plasma Cell
Hemorrhage
Humans
Infant
Mediastinal Neoplasms
Mediastinum*
Myofibroblasts*
Recurrence
Tomography, X-Ray Computed
Full Text Links
  • CPHO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr